ZYME250117C22500
- 0.00
- 0.000.00%
Zymeworks Newsroom
Dell Technolodies, Accolade, and More Stocks See Action From Activist Investors -- Barrons.com
Zymeworks (NASDAQ:ZYME) Shareholder Returns Have Been Favorable, Earning 79% in 3 Years
12 Health Care Stocks Moving In Thursday's Pre-Market Session
The Past Five Years for Zymeworks (NASDAQ:ZYME) Investors Has Not Been Profitable
Insider Purchase: Director at $ZYME (ZYME) Buys 74,125 Shares
Big Biotech Fund Loads Up on a Stock That Surged in 2024, and a Loser -- Barrons.com
Ecor1 Capital Increases Stake in Zymeworks With $2.97 Million Purchase
Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Maintains Target Price $28
Zymeworks (ZYME) Receives a Buy From Stifel Nicolaus
Zymeworks Sets Strategic Milestones for 2025-2026 With Focus on Novel Therapeutics
Express News | Zymeworks Inc - Ind Applications for ZW209 and ZW1528 Expected in 2026
Express News | Zymeworks Inc - Ind Applications for ZW220 and ZW251 in Solid Tumors Expected in 2025
Zymeworks Expects $324M Cash Resources, Plus $25M Milestone, To Fund Operations Into 2H-2027
Express News | Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026
Wall Street Analysts Believe Zymeworks (ZYME) Could Rally 41.36%: Here's Is How to Trade
Landsea Homes, LandBridge, and More Stocks See Action From Activist Investors -- Barrons.com
Zymeworks(ZYME.US) 10% Shareholder Buys US$5.32 Million in Common Stock
Insider Purchase: Director at $ZYME (ZYME) Buys 11,958 Shares
Ecor1 Capital Increases Stake in Zymeworks With $1.88 Million Purchase
(SEC Amendment) Zymeworks(ZYME.US) 10% Shareholder Buys US$17.54 Million in Common Stock